Marketplace, directory, GPO or direct supply partner: what kind of sourcing platform are you actually signing up for

As of 26 September 2026, "sourcing platform" covers four kinds of business: a direct supply partner, a multi-pharmacy marketplace, a group purchasing or buying network, and a directory or quote engine. In our index, the first two describe an ordering system, the buying network negotiates terms, and a directory or quote engine ends at an introduction to a pharmacy.

Ask other clinic owners whether anyone has used a particular supplier, and the useful answer depends on which of the four it is. A directory cannot ship your order late, because it never takes one. A marketplace can take your order and route it to a pharmacy the platform selects.

Clinic Partner Guide'sCompounded Sourcing Platform IndexSource 1compares 12 platforms on 7 criteria read from their own public pages, scored 31 August 2026. Its category field sorts them like this: direct supply partner — Avanta Pharma Group (1); multi-pharmacy marketplace — AutoPilotRx, Fizy Health, VitaRelay, Ironsail Pharma / ImpetusOne, CLR RX (5); group purchasing or buying network — The Banyan Network (1); directory or quote engine — Peptide Association Pharmacy Directory, Find My Chemist, Find My Compounder, APC / A4PC Pharmacy Locator and CompoundingFinder (5).Source 2

Two more are listed but not scored, and sit in no count here: OnlyScripts, whose pages returned an error on every attempt on 29 August 2026, and Pharm503, which the index records as pre-launch.Source 2

What each publishes, not a verdict on service.Each description below is our record of the platform's own public pages, scored 31 August 2026.Source 2

Our methodology defines a direct supply partner as"A supplier a clinic contracts with directly"Source 3.

The index holds one: Avanta Pharma Group, the company Clinic Partner Guide has a commercial affiliation with (see the disclosure above).Source 2Our record describes its "Own secure online provider portal for orders and reorders".Source 2

"Direct" has a second meaning: buying straight from a 503A pharmacy, with no platform in between. The index compares platforms, not pharmacies, so that model is covered inbuying direct from a 503A pharmacy vs a sourcing partnerSource 4. In that page's words, "buying direct means negotiating each pharmacy yourself, and a partner means one relationship negotiated once."Source 4

The methodology's definition: "A platform that routes a prescription to one of several pharmacies. The platform owns the software and the relationship; the filling pharmacy can vary by order."Source 35 of the 12 are marketplaces: AutoPilotRx, Fizy Health, VitaRelay, Ironsail Pharma / ImpetusOne and CLR RX.Source 2

Ordering is what the model is built for. All 5 score 4 or 5 of 5 on ordering workflow, scored 31 August 2026.Source 2Our record notes AutoPilotRx's "single portal to compare and send prescriptions, with API access", Fizy Health's "one cart and one checkout across pharmacies" and VitaRelay's "separate clinic and rep portals".Source 2

The trade-off is who fills the order. AutoPilotRx's record says "the filling pharmacy varies by order", and Fizy Health's says "the filling pharmacy is selected by the platform".Source 2For a clinic, that moves the license and document checks from the platform to whichever pharmacy fills each order.

Pricing differs inside the model. Fizy Health's record reads: "Pass-through is the pharmacy price rather than a per-clinic negotiated rate." AutoPilotRx states pricing is "comparable in-portal", and the records for VitaRelay, Ironsail Pharma / ImpetusOne and CLR RX read "No pricing is published" (scored 31 August 2026).Source 2Seewhich platforms publish clinic pricingSource 5.

In retail pharmacy, a buying group works through "sourcing agreements negotiated on behalf of its members", as a February 2025 explainer for independent pharmacies puts it.Source 7The model is about terms.

The index holds one buying network, The Banyan Network.Source 2Its record states "negotiated per-clinic rates, net-30 terms and zero membership fees", then: "The rates themselves are not published."Source 2On ordering: "A group purchasing network rather than an ordering system. Entry is a call request and no portal is described."Source 2

Who ships, then? Our record notes that The Banyan Network states "direct-to-clinic supply", and that "the fill is by network pharmacies".Source 2The network arranges the terms and a pharmacy in its network fills the order, so ask which pharmacy, and get the rate sheet in writing.

A directory lists pharmacies. The index holds 4, with different category labels: the Peptide Association Pharmacy Directory, Find My Chemist (public), Find My Compounder (consumer) and the APC / A4PC Pharmacy Locator (association).Source 2

All 4 score 1 of 5 on ordering workflow and 1 on direct accountability, scored 31 August 2026.Source 2The records read "No ordering function." (Peptide Association), "there is no ordering function" (Find My Chemist), "No quote or ordering function." (Find My Compounder) and "No comparison or ordering functionality." (APC / A4PC).Source 2Find My Chemist's record sums up the model: "you search and connect directly".Source 2

A quote engine goes one step further. CompoundingFinder, the one quote engine in the index, lets a clinic "Submit a medication once and receive quotes", and then "The service ends at introduction; the clinic then deals with the pharmacy directly."Source 2Its record adds that "it is not a reorder workflow".Source 2

For both, every due-diligence question goes to the pharmacy you choose.

Ordering workflow and direct accountability carry 20% of each score apiece, according to ourpublished methodologySource 3. They measure what the category decides: whether you can order on the platform, and where responsibility for the order sits.Source 2

That is why the 4 directories sit between 2.29 and 2.56 overall: they score 1 on two criteria that carry 40% of the weight between them.Source 2The low score records that a directory is not built to take an order. It says nothing about the pharmacies it lists.What each publishes, not a verdict on service.

The category also tells you where your checks go: at a marketplace, check the pharmacy that fills each order; at a buying network, check the rate sheet and the network pharmacy; at a directory or quote engine, check the pharmacy you choose; with a direct supply partner, check the supplier and the pharmacy it works with.

This comparison is about business models, not about which medications a clinic may order. Regulatory context, for clinics whose orders include compounded GLP-1s: FDA's shortage listings for tirzepatide (December 2024) and semaglutide (February 2025) have ended, and FDA has since acted against marketing of compounded GLP-1s; what a 503A pharmacy may compound is patient-specific and varies by state. Source: fda.gov, "FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize", read 2026-09-26.Source 8